Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons
- 1 November 2000
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 61 (1) , 55-68
- https://doi.org/10.1016/s0376-8716(00)00123-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptorsPublished by Elsevier ,2003
- Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboonsDrug and Alcohol Dependence, 2000
- Differentiating benzodiazepine- and barbiturate-like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil and zaleplon in two- versus three-lever proceduresBehavioural Pharmacology, 2000
- Zaleplon displays a selectivity to recombinant GABAA receptors different from zolipdem, zopiclone and benzodiazepinesNeuroscience Research Communications, 1999
- A Review of the Preclinical Development of Zaleplon, a Novel Non‐Benzodiazepine Hypnotic for the Treatment of InsomniaCNS Drug Reviews, 1997
- Pharmacokinetics and Pharmacodynamics of Triazolam After Two Intermittent Doses in Obese and Normal-Weight MenJournal of Clinical Psychopharmacology, 1995
- A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine HypnoticThe Journal of Clinical Pharmacology, 1994
- Drug discrimination analysis of endogenous neuroactive steroids in ratsEuropean Journal of Pharmacology, 1993
- Differential generalization to pentobarbital in rats trained to discriminate lorazepam, chlordiazepoxide, diazepam, or triazolamPsychopharmacology, 1989
- Asymmetrical cross‐generalization in drug discrimination with lorazepam and pentobarbital training conditionsDrug Development Research, 1989